Clinical Efficacy and Safety of Low‐Energy Extracorporeal Shock Wave Therapy for Various Conditions of Deep Dermal and Subdermal Fibrosis
Skin Research and Technology · 2024
DOI: 10.1111/srt.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Jeongah Ko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ko Jung A Clinic, Seoul, South Korea. Hauptthemen laut MEDLINE: Extracorporeal Shockwave Therapy, Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Extracorporeal shock wave therapy (ESWT) enhances extracellular matrix remodeling and tissue regeneration by promoting growth factor release, regulating blood and lymphatic flows, and reducing fat and fibrotic tissues. Focused shock wave therapy (F‐SWT), radial shock wave therapy (R‐SWT), and combined F‐SWT and R‐SWT have been used to deliver different patterns of shock energy depending on the characteristics of the target lesions.
Methods
We investigated the efficacy and safety of ESWT in patients with dermal and subdermal fibrosis. Fifty‐two patients treated with F‐SWT and/or R‐SWT for dermal and subdermal fibrosis caused due to various reasons were retrospectively analyzed by reviewing their medical records, clinical images, and ultrasound study images.
Results
The mean number of pulses administered for F‐SWT on the cheek, temple, and chin were 2600.0 ± 1040.8 shocks/session and for R‐SWT were 5080.0 ± 2234.6 pulses/session, and the number of treatment sessions were 8.0 ± 4.4. In patients who were treated with ESWT on the abdomen, the mean number of pulses for F‐SWT were 2600.0 ± 2408.3 shocks/session and for R‐SWT were 8400.0 ± 894.4 pulses/session, and the number of treatment sessions were 3.2 ± 1.6. Most patients were satisfied with the results. Pain during ESWT was well tolerated and post‐ESWT edema was more common in R‐SWT than in F‐SWT.
Conclusion
Our data demonstrated that ESWT effectively and safely improved the clinical appearance and functional movement of patients with dermal and subdermal fibrosis caused due to various reasons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ko Jung A Clinic, Seoul, South Korea.
- Yonsei Seran Dermatology and Laser Clinic, Seoul, South Korea.
ORCID-Profile: Sung Bin Cho
Zitieren
APA
Ko, J., & Cho, S. B. (2024). Clinical Efficacy and Safety of Low‐Energy Extracorporeal Shock Wave Therapy for Various Conditions of Deep Dermal and Subdermal Fibrosis. Skin Research and Technology. https://doi.org/10.1111/srt.70082
Vancouver
Ko J, Cho SB. Clinical Efficacy and Safety of Low‐Energy Extracorporeal Shock Wave Therapy for Various Conditions of Deep Dermal and Subdermal Fibrosis. Skin Research and Technology. 2024. doi:10.1111/srt.70082
BibTeX
@article{Ko2024,
author = {Ko, Jeongah and Cho, Sung Bin},
title = {Clinical Efficacy and Safety of Low‐Energy Extracorporeal Shock Wave Therapy for Various Conditions of Deep Dermal and Subdermal Fibrosis},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.70082}
}
EUVIMED